ArticleOncotarget2016

Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial.

Matthew D Hale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.